Ipafricept: Phase Ib data

Top-line data from 17 evaluable patients with recurrent platinum-sensitive ovarian cancer in an open-label, dose-escalation, U.S. Phase Ib trial showed

Read the full 204 word article

How to gain access

Continue reading with a
two-week free trial.